SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-066114
Filing Date
2021-12-20
Accepted
2021-12-17 19:29:03
Documents
14
Period of Report
2021-12-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea152607-8k_inmedpharma.htm   iXBRL 8-K 38484
2 NEWS RELEASE, DATED DECEMBER 17, 2021 ea152607ex99-1_inmedpharma.htm EX-99.1 13742
6 GRAPHIC ex99-1_001.jpg GRAPHIC 5348
  Complete submission text file 0001213900-21-066114.txt   236724

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20211217.xsd EX-101.SCH 3031
4 XBRL LABEL FILE inm-20211217_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inm-20211217_pre.xml EX-101.PRE 22364
7 EXTRACTED XBRL INSTANCE DOCUMENT ea152607-8k_inmedpharma_htm.xml XML 3621
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211503244
SIC: 2834 Pharmaceutical Preparations